Current and future trends in the application of HPLC-MS to metabolite-identification studies

Drug Discovery Today

Volumn 12, Issue 5-6, 2007, Pages 249-256

  Castro Perez, Jose M ^a  

^a WATERS CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL EQUIPMENT; DRUG IDENTIFICATION; DRUG INDUSTRY; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; INFORMATION PROCESSING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITE; REVIEW; SCREENING; SEPARATION TECHNIQUE;

BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; DRUG INDUSTRY; HUMANS; MASS SPECTROMETRY; PHARMACEUTICAL PREPARATIONS;

EID: 33847212842     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2007.01.007     Document Type: Review

References (40)

1. Kola I., and Landis J. Can the pharmaceutical industry reduce attrition rates?. Nat. Rev. Drug Discov. 3 (2004) 711-715
2. Watt A.P., et al. Metabolite identification in drug discovery. Curr. Opin. Drug Discov. Dev. 6 (2003) 57-65
3. Bateman K.P., et al. Interspecies in vitro metabolism of the phosphodiesterase-4 (PDE4) inhibitor L-454,560. J. Mass Spectrom. 41 (2006) 771-780
4. Clarke N.J., et al. Systematic LCMS metabolite identification in drug discovery. Anal. Chem. 73 (2001) 430A-439A
5. Castro-Perez J., et al. Advances in MS-based approaches for drug and metabolism studies. Chromatographia 55 (2002) S59-S63
6. Baillie T.A., and Davis M.R. Mass spectrometry in the analysis of glutathione conjugates. Biol. Mass Spectrom. 22 (1993) 319-325
7. Baillie T.A., et al. Contemporary issues in toxicology: drug metabolites in safety testing. Toxicol. Appl. Pharmacol. 181 (2002) 188-196
8. Lafaye A., et al. Profiling of sulfoconjugates in urine using precursor ion and neutral loss scans in tandem mass spectrometry. Application to the investigation of heavy metal toxicity in rats. J. Mass Spectrom. 39 (2004) 364-655
9. Mutlib A.E., and Shockcor J.P. Application of LCMS, LCMMR, NMR and stable isotopes in identifying and characterizing metabolites. In: Le J.S., Obatch R.S., and Fisher M.B. (Eds). Drug Metabolizing Enzymes Cytochrome P450 and Other Enzymes in Drug Discovery and Development (2003), FontisMedia S.A. and Marcel DeMcer 33-83
10. WeidoIf L., and Covey T.R. Studies on the metabolism of omeprazole in rat using liquid chromatography/ionspray mass spectrometry and isotope cluster technique with omeprazole. Rapid Commun. Mass Spectrom. 6 (1992) 192-196
11. Corcoran O., et al. Directly coupled liquid chromatography with inductively coupled plasma mass spectrometry and orthogonal acceleration time-of-flight mass spectrometry for the identification of drug metabolites in urine: application to diclofenac using chlorine and sulfur detection. Rapid Commun. Mass Spectrom. 14 (2000) 2377-2384
12. Jackson P.J., et al. Use of electrospray ionization and neutral loss liquid chromatography/tandem mass spectrometry in drug metabolism studies. J. Mass Spectrom. 30 (1995) 446-451
13. Jemal M., et al. A strategy for metabolite identification using triple quadrupole mass spectrometry with enhanced resolution and accurate mass capability. Rapid Commun. Mass Spectrom. 17 (2003) 2732-2740
14. Kostiainen R., et al. Liquid chromatogtaphy/atmosphetic pressure ionization-mass spectrometry in drug metabolism studies. J. Mass Spectrom. 38 (2003) 357-372
15. Foltz D.J., et al. Narrow-bore sample trapping and chromatography combined with quadrupole/time-of-flight mass spectrometry for ultra-sensitive identification of in vivo and in vitro metabolites. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 825 (2005) 144-151
16. Castro-Perez J., et al. A high-throughput liquid chromatography/tandem mass spectrometry method for screening glutathione conjugates using exact mass neutral loss acquisition. Rapid Commun. Mass Spectrom. 19 (2005) 798-804
17. Sundstrom I., et al. Identification of glucuronide conjugates of ketobemidone and its phase I metabolites in human urine utilizing accurate mass and tandem time-of-flight mass spectrometry. J. Mass Spectrom. 37 (2002) 414-420
18. Sleno L., et al. Assigning product ions from complex MSMS spectra: The importance of mass uncertainty and resolving power. J. Am. Soc. Mass Spectrom. 16 (2005) 183-198
19. Plumb R.S., et al. Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids. Rapid Commun. Mass Spectrom. 17 (2003) 2632-2638
20. Xia Y.-Q., et al. Use of a quadrupole linear ion trap mass spectrometer in metabolite identification and bioanalysis. Rapid Commun. Mass Spectrom. 17 (2003) 1137-1145
21. Plumb R.S., et al. Generation of ultrahigh peak capacity LC separations via elevated temperatures and high linear mobile-phase velocities. Anal. Chem. 78 (2006) 7278-7283
22. Plumb R.S., et al. A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: application to age, gender and diurnal variation in normal/Zucker obese rats and black, white and nude mice. Analyst 30 (2005) 844-849
23. Wilson I.D., et al. High resolution 'ultra performance' liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J. Proteome Res. 4 (2005) 591-598
24. Castro-Perez J., et al. Increasing throughput and information content for in vitro drug metabolism experiments using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer. Rapid Commun. Mass Spectrom. 19 (2005) 843-848
25. Plumb R., et al. Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 18 (2004) 2331-2337
26. Churchwell M.I., et al. Improving LC-MS sensitivity through increases in chromatographic performance: comparisons of UPLC-ES/MS/MS to HPLC-ES/MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 825 (2005) 134-143
27. Zhu M., et al. Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes. Drug Metab. Dispos. 33 (2005) 500-507
28. Liu D.Q., and Hop C.E. Strategies for characterization of drug metabolites using liquid chromatography-tandem mass spectrometry in conjunction with chemical derivatization and on-line H/D exchange approaches. J. Pharm. Biomed. Anal. 37 (2005) 1-18
29. Yu X., et al. Identification of in vitro metabolites of indinavir by 'intelligent automated LC-MS/MS' (INTAMS) utilizing triple quadrupole tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 10 (1999) 175-183
30. Mortishire-Smith R.J., et al. Kirby Accelerated throughput metabolic route screening in early drug discovery using high-resolution liquid chromatography/quadrupole time-of-flight mass spectrometry and automated data analysis. Rapid Commun. Mass Spectrom. 19 (2005) 2659-2670
31. Zhang H., et al. A software filter to remove interference ions from drug metabolites in accurate mass liquid chromatography/mass spectrometric analyses. J. Mass Spectrom. 38 (2003) 1110-1112
32. Zhu M., et al. Detection and characterization of metabolites in biological matrices using mass defect filtering of liquid chromatography/high resolution mass spectrometry data. Drug Metab. Dispos. 34 (2006) 1722-1733
33. Balogh M.P. Spectral interpretation, part ii: tools of the trade, MS- the practical art. LC GC 24 (2006) 762-769
34. Anari M.R., et al. Integration of knowledge-based metabolic predictions with liquid chromatography data-dependent tandem mass spectrometry for drug metabolism studies: application to studies on the biotransformation of indinavir. Anal. Chem. 76 (2004) 823-832
35. Wrona M., et al. 'All-in-one' analysis for metabolite identification using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry with collision energy switching. Rapid Commun. Mass Spectrom. 19 (2005) 2597-2602
36. Giles K., et al. An investigation of the mobility separation of some peptide and protein ions using a new hybrid quadrupole/traveling wave IMS/oa-ToF instrument. Int. J. Mass Spectrom. (2006) 10.1016/ijms.2006.07.021
37. Ruotolo B.T., et al. Evidence for macromolecular protein rings in the absence of bulk water. Science 310 (2005) 1658-1661
38. Cornett D.S., et al. A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer. Mol. Cell. Proteomics 5 (2006) 1975-1983
39. Khatib-Shahidi S., et al. Direct molecular analysis of whole-body animal tissue sections by imaging MALDI mass spectrometry. Anal. Chem. 78 (2006) 6448-6456
40. Chaurand P., et al. Molecular imaging of thin mammalian tissue sections by mass spectrometry. Curr Opin Biotechnol. 4 (2006) 431-436